• Zikriyya Melati Rahmany Mataram University
  • Yusra Pintaningrum
  • Romi Ermawan
Keywords: in-stent restenosis, the duration of stent implantation, coronary angiography evaluation, coronary heart disease


Background : in-stent restenosis is a problem which happens in patient whom underwent percutaneous coronary intervention procedure. The aim of this study is to know the correlation between the duration of stent implantation and significant in-stent restenosis case on coronary heart disease (CHD) patient under coronary angiography evaluation.

Method : This study is an observational analytic study with cross sectional method on CHD patient under coronary angiography evaluation in West Nusa Tenggara Public Hospital. The data were obtained from heart catheterization laboratory and medical records from January, 2018 until June, 2020. The analysis was done by eta correlative hypothesis using SPSS Ver. 26.0.

Result: This research has 89 subjects. The statistical analysis showed p = 0.174 and r = 0.251

Conclusion: There is no correlation between the duration of stent implantation and significant in-stent restenosis case on CHD patient under coronary angiography evaluation in West Nusa Tenggara Public Hospital.

Key Word: In-stent restenosis, the duration of stent implantation, coronary angiography evaluation, coronary heart diasease


1. Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2017. 2017.
2. World Health Organization (WHO). Cardiovascular diseases ( CVDs ) [Internet]. World Health Organization. 2017. Available from:
3. Kementerian Kesehatan BL. Situasi Kesehatan Jantung. 2014.
4. Cheng G, Chang FJ, Wang Y, You PH, Chen HC, Han WQ, et al. Factors influencing stent restenosis after percutaneous coronary intervention in patients with coronary heart disease: A clinical trial based on 1-year follow-up. Med Sci Monit. 2019;25:240–7.
5. Jukema JW, Verschuren JJW, Ahmed TAN, Quax PHA. Restenosis after PCI. Part 1: Pathophysiology and risk factors. Nat Rev Cardiol [Internet]. 2012;9(1):53–62. Available from:
6. Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: A review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150–62.
7. Her A, Shin E. Current Management of In-Stent Restenosis. Korean Circ J. 2018;48(5):337–49.
8. Lee MS, Banka G. In-stent Restenosis. Interv Cardiol Clin [Internet]. 2015;5(2):211–20. Available from:
9. Sajadian M, Alizadeh L, Ganjifard M, Mardani A, Ansari MA, Falsoleiman H. Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty GMJ. Gmj [Internet]. 2018;7:961. Available from: www.gmj.ir
10. Marino BCA, Nascimento GA, Rabelo W, Marino MA, Marino RL, Ribeiro ALP. Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes. Arq Bras Cardiol. 2015;104(5):375–86.
11. Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Lee CW, et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation intravascular ultrasound analysis. Circ Cardiovasc Interv. 2011;4(1):9–14.
12. Mitra AK, Agrawal DK. In stent Restenosis: Bane of the Stent Era. J Clin Pathol. 2006;59(3):232–9.
13. Maas AHEM, Appelman YEA. Gender differences in coronary heart disease. Netherlands Hear J. 2010;18(12):598–603.
14. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):1–12.
15. Pathak LA, Shirodkar S, Ruparelia R, Rajebahadur J. Coronary artery disease in women. Indian Heart J [Internet]. 2017;69(4):532–8. Available from:
16. Eugenmed T, Clinical C, Group S, Regitz-zagrosek V, Oertelt-prigione S, Prescott E, et al. Gender in cardiovascular diseases?: impact on clinical manifestations , management , and outcomes. 2016;24–34.
17. Ashley E, Niebaur J. Coronary artery disease. In: Cardiology Explained. 2004.
18. Dhingra R, Vasan RS. Age As a Risk Factor. Med Clin North Am. 2012;96(1):87–91.
19. North BJ, Sinclair DA. The Intersection Between Aging and Cardiovascular Disease. Circ Res. 2012;110(8):1097–108.
20. Brown JC, Gerhardt TE, Kwon E. Risk Factors for Coronary Artery Disease. Statpearls. 2020;
21. Hussain MA, Mamun A Al, Peters SAE, Woodward M, Huxley RR. The burden of cardiovascular disease attributable to major modifiable risk factors in Indonesia. J Epidemiol. 2016;26(10):515–21.
22. Maharani A, Sujarwoto, Praveen D, Oceandy D, Tampubolon G, Patel A. Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study. PLoS One. 2019;14(4):1–13.
23. Kapoor R, Vyas S, Patel P, Mehta H, Mehta P, Modi J, et al. Short Communication A case-control study of risk factors for ischemic heart disease in patients attending tertiary care hospitals in India. 2013;3(1):57–60.
24. Djafri D, Monalisa, Elytha F, Machmud R. Efek modifikasi faktor risiko modifiable penyakit jantung koroner: a hospital-based matched case control study. J Kesehat Masy Andalas. 2017;11(2):93–9.
25. Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246.
26. Mazin I, Paul G, Asher E. Neoatherosclerosis – From basic concept to clinical implication. Thromb Res [Internet]. 2019;178(July 2018):12–6. Available from:
27. Bhatt DL. Percutaneous coronary intervention in 2018. JAMA - J Am Med Assoc. 2018;319(20):2127–8.
28. Mehilli J, Kastrati A, Bollwein H, Dibra A, Schühlen H, Dirschinger J, et al. Gender and restenosis after coronary artery stenting. Eur Heart J. 2003;24(16):1523–30.
29. Yamaji K, Shiomi H, Morimoto T, Toyota T, Ono K, Furukawa Y, et al. Influence of sex on long-term outcomes after implantation of bare-metal stent a multicenter report from the coronary revascularization demonstrating outcome study-kyoto (CREDO-Kyoto) registry cohort-1. Circulation. 2015;132(24):2323–33.
30. Regueiro A, Fernández-Rodríguez D, Brugaletta S, Martín-Yuste V, Masotti M, Freixa X, et al. Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial. Rev Española Cardiol (English Ed. 2015;68(5):382–9.
31. Cho JY. Identification of Risk Factors Influencing In-Stent Restenosis with Acute Coronary Syndrome Presentation. Chonnam Med J. 2017;53(3):203.
32. Tang L, Cui QW, Liu DP, Fu YY. The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention. Med (United States). 2019;98(50):1–7.
33. Mohan S, Dhall A. A comparative study of restenosis rates in bare metal and drug-eluting stents. Int J Angiol. 2010;19(2).
34. Ogobuiro I, Wehrle CJ, Tuma F. Anatomy , Thorax , Heart Pulmonary Arteries Blood Supply and Lymphatics. Statpearls. 2020.
35. Weber C, Brown KN, Borger J. Anatomy, Thorax, Heart Anomalous Left Anterior Descending (LAD) Artery [Internet]. StatPearls. 2020. Available from:
36. Wihanda D, Alwi I, Yamin M, Shatri H, Mudjaddid E. Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention. Acta Med Indones. 2015;47(3):209–15.
37. Calais F, Lagerqvist B, Leppert J, James SK, Fröbert O. Proximal coronary artery intervention: Stent thrombosis, restenosis and death. Int J Cardiol [Internet]. 2013;170(2):227–32. Available from:
38. Schmidt W, Lanzer P, Behrens P, Brandt-Wunderlich C, Öner A, Ince H, et al. Direct comparison of coronary bare metal vs. drug-eluting stents: Same platform, different mechanics? Eur J Med Res [Internet]. 2018;23(1):1–12. Available from:

Most read articles by the same author(s)